DHI
37
-3
RSG
45
-2
FFIV
51
4
OMC
66
-3
CNP
52
3
PRGO
43
4
PNR
54
3
VIX
19
-6
HRB
42
-4
WHR
48
-2
PH
64
2
HSY
51
8
HON
68
-2
CA
21
-9
DUK
55
3
AON
65
3
BLK
63
5
MS
76
2
PEG
50
4
NI
67
2
DHI
37
-3
RSG
45
-2
FFIV
51
4
OMC
66
-3
CNP
52
3
PRGO
43
4
PNR
54
3
VIX
19
-6
HRB
42
-4
WHR
48
-2
PH
64
2
HSY
51
8
HON
68
-2
CA
21
-9
DUK
55
3
AON
65
3
BLK
63
5
MS
76
2
PEG
50
4
NI
67
2
Financhill
Back

Charter Communications, Inc. Vs. Zenas BioPharma, Inc. Industry Stock Comparison

Sell
14

CHTR
Charter Communications, Inc.

Last Price:
$206.32
Seasonality Move:
6.54%
Buy
60

ZBIO
Zenas BioPharma, Inc.

Last Price:
$41.85
Seasonality Move:
0.59%
Sell
14
Charter Communications, Inc. (CHTR) is a Sell

Is Charter Communications, Inc. a Buy, Sell or Hold?

  • The current Charter Communications, Inc. [CHTR] share price is $206.02. The Score for CHTR is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • CHTR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
60
Zenas BioPharma, Inc. (ZBIO) is a Buy

Is Zenas BioPharma, Inc. a Buy, Sell or Hold?

  • The current Zenas BioPharma, Inc. [ZBIO] share price is $42.33. The Score for ZBIO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • ZBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CHTR Stock Price Chart

What is Charter Communications, Inc.'s stock price today?

  • The Charter Communications, Inc. share price today is $206.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CHTR is experiencing selling pressure, which indicates risk of future bearish movement.

ZBIO Stock Price Chart

What is Zenas BioPharma, Inc.'s stock price today?

  • The Zenas BioPharma, Inc. share price today is $42.33
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.

CHTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.4 Sell
Relative Strength Index (14 RSI): 45.06 Sell
Chaikin Money Flow: -772370 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (198.19 - 208.51) Buy
Bollinger Bands (100): (214.66 - 271.24) Sell

ZBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.47 Buy
Relative Strength Index (14 RSI): 61.08 Buy
Chaikin Money Flow: 587345 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.32 - 39.82) Buy
Bollinger Bands (100): (17.72 - 34.64) Buy

CHTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 208.33 Sell
20-day SMA: 204.46 Buy
50-day SMA: 219.32 Sell
200-day SMA: 310.16 Sell
8-day EMA: 207.05 Sell
20-day EMA: 207.48 Sell
50-day EMA: 220.91 Sell
200-day EMA: 284.37 Sell

ZBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.46 Buy
20-day SMA: 37.97 Buy
50-day SMA: 33.51 Buy
200-day SMA: 18.21 Buy
8-day EMA: 24.11 Buy
20-day EMA: 12.41 Buy
50-day EMA: 5.54 Buy
200-day EMA: 1.47 Buy

Charter Communications, Inc. Earnings Growth & CHTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.29 per share, and an increase next year of $6.91 per share.

Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.

Charter Communications, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Zenas BioPharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):